Package 51862-339-01

Brand: chlorzoxazone

Generic: chlorzoxazone
NDC Package

Package Facts

Identity

Package NDC 51862-339-01
Digits Only 5186233901
Product NDC 51862-339
Product ID 51862-339_ffd326e9-a80a-275a-e053-6394a90a213a
Description

100 TABLET in 1 BOTTLE (51862-339-01)

Marketing

Marketing Status
Marketed Since 2020-07-31
Brand chlorzoxazone
Generic chlorzoxazone
Sample Package No

Linked Drug Pages (1)

Chlorzoxazone ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "ffd326e9-a80a-275a-e053-6394a90a213a", "openfda": {"nui": ["N0000175730", "N0000175737"], "upc": ["0351862338016", "0351862340019", "0351862339013"], "unii": ["H0DE420U8G"], "rxcui": ["197502", "1088934", "1088936"], "spl_set_id": ["5238c99e-d36e-4376-ab05-ca2535213d58"], "pharm_class_pe": ["Centrally-mediated Muscle Relaxation [PE]"], "pharm_class_epc": ["Muscle Relaxant [EPC]"], "manufacturer_name": ["Mayne Pharma Commercial LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (51862-339-01)", "package_ndc": "51862-339-01", "marketing_start_date": "20200731"}], "brand_name": "Chlorzoxazone", "product_id": "51862-339_ffd326e9-a80a-275a-e053-6394a90a213a", "dosage_form": "TABLET", "pharm_class": ["Centrally-mediated Muscle Relaxation [PE]", "Muscle Relaxant [EPC]"], "product_ndc": "51862-339", "generic_name": "chlorzoxazone", "labeler_name": "Mayne Pharma Commercial LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Chlorzoxazone", "active_ingredients": [{"name": "CHLORZOXAZONE", "strength": "500 mg/1"}], "application_number": "ANDA211849", "marketing_category": "ANDA", "marketing_start_date": "20200731", "listing_expiration_date": "20261231"}